This retrospective study obtained approval from the Ethics Committee of Saitama Medical University Hospital, in accordance with the Declaration of Helsinki, and acquired patient consent (Institutional Review Board 19079.01). Data from 152 patients with Gass classification stages 2, 3, and 4 IMH who underwent Swept-source OCTA imaging at our institution between February 2018 and June 2024 using the PLEX Elite 9000 (Carl Zeiss Meditec, Inc., Dublin, CA) were retrospectively analyzed. Collected data included preoperative best-corrected visual acuity (BCVA), slit-lamp microscopy, noncontact tonometry (TONOREF II, Nidek, Gamagori, Japan), fundus photography (CX-1, Canon, Tokyo, Japan), ocular axial length measurement (Optical Biometer OA-2000, Tomei Corporation, Nagoya, Japan), and retinal thickness analysis via spectral domain OCT (SD-OCT) (Spectralis HRA 2, Heidelberg Engineering, Heidelberg, Germany). Exclusion criteria comprised patients with an axial length of 26 mm or greater, diabetic retinopathy and maculopathy, glaucoma, traumatic MH, retinal detachment, prior endophthalmitis surgery, or poor-quality en face images from OCTA imaging. Surgery was performed by several experienced surgeons. All patients except pseudophakia first underwent phacoemulsification and intraocular lens (IOL) implantation. Standard three-port, sutureless, pars plana vitrectomy and internal limiting membrane peeling were performed. In all cases, the macular holes were closed. Air or sulphur hexafluoride (SF6) was used as an intravitreal tamponade. Postoperatively, patients were advised to posture face down by day from 3 to 7 days. Postoperative BCVA was measured within 1 month after surgery, after the intraocular gas had disappeared.